Trial Profile
A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy; Tonic-clonic epilepsy
- Focus Pharmacodynamics
- Sponsors UCB Pharma Inc
- 03 May 2014 Results presented at the 66th Annual Meeting of the American Academy of Neurology.
- 10 Dec 2013 Results presented at the 67th Annual Meeting of the American Epilepsy Society.
- 17 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.